Pierre Dodey

Deltakephalin, Tyr-D-Thr-Gly-Phe-Leu-Thr: A new highly potent and fully specific agonist for opiate δ-receptors

Jean‐Marie Zajac, G. Gacel, Françis Petit et al. · Biochemical and Biophysical Research Communications · 1983 · 170 citations

Molecular Pharmacology, Specific Agonist, Medicine +8

Design, Synthesis, and Evaluation of a Novel Series of Indole Sulfonamide Peroxisome Proliferator Activated Receptor (PPAR) α/γ/δ Triple Activators: Discovery of Lanifibranor, a New Antifibrotic Clinical Candidate

Benaı̈ssa Boubia, Olivia Poupardin, Martine Barth et al. · Journal of Medicinal Chemistry · 2018 · 106 citations · Full text

Pharmaceutical Science, Pharmacotherapy, Pharmaceutical Chemistry +19

Pharmacological profile of LF 16-0687, a new potent non-peptide bradykinin B2 receptor antagonist

Didier Pruneau, Jean Luc Paquet, J.M. Luccarini et al. · Immunopharmacology · 1999 · 94 citations

Biochemistry, Medicine, Peptide Library +7

Design and Synthesis of Potent Bradykinin Agonists Containing a Benzothiazepine Moiety

Muriel Amblard, Isabelle Daffix, Philippe Bedos et al. · Journal of Medicinal Chemistry · 1999 · 62 citations · Full text

Combinatorial Chemistry, Organic Chemistry, Pharmacotherapy +20

Antinociceptive Pharmacology of N-[[4-(4,5-Dihydro-1 H-imidazol-2-yl)phenyl]methyl]-2-[2-[[(4-methoxy-2,6-dimethylphenyl) sulfonyl]methylamino]ethoxy]-N-methylacetamide, Fumarate (LF22-0542), a Novel Nonpeptidic Bradykinin B1 Receptor Antagonist

Frank Porreca, T.W. Vanderah, W. Guo et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 43 citations